A preliminary study of a health related quality of life assessment of priority symptoms in advanced lymphoma: the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy – Lymphoma Symptom Index-Reference-Cited by-同舟云学术

A preliminary study of a health related quality of life assessment of priority symptoms in advanced lymphoma: the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy – Lymphoma Symptom Index

Published:2013-02-07 Issue:9 Volume:54 Page:1942-1946
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Hlubocky Fay J.,Webster Kimberly,Beaumont Jennifer,Cashy John,Paul Diane,Abernethy Amy,Syrjala Karen L.,Von Roenn Jamie,Cella David

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2012.762977

Reference28 articles.

1. Cancer statistics, 2011

3. Professional rehabilitation of lymphoma patients: a study of psychosocial factors associated with return to work

4. Non-Hodgkin's lymphoma

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Feasibility of collecting longitudinal patient-reported outcomes in individuals with relapsed or refractory large B-cell lymphoma who received chimeric antigen receptor T-cell (CART) therapy;BMC Cancer;2024-08-09

2. Content validation of the National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Lymphoma Symptom Index-18 (NFLymSI-18) in indolent B-cell non-Hodgkin’s lymphoma;Journal of Patient-Reported Outcomes;2024-07-09

3. Survivorship after Hodgkin lymphoma and the right to be forgotten;Current Opinion in Oncology;2024-06-24

4. Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study;Nature Medicine;2024-06-03

5. Lisocabtagene maraleucel for second-line relapsed or refractory large B-cell lymphoma: patient-reported outcomes from the PILOT study;Haematologica;2023-08-31